Comparative analysis of therapeutic plasma exchange vs. standard management in hypertriglyceridemia-induced acute pancreatitis: triglyceride reduction and clinical outcomes.
Acute pancreatitis
Hypertriglyceridemia
Insulin
Prognosis
Therapeutic plasma exchange
Journal
Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
received:
22
02
2024
accepted:
24
05
2024
medline:
4
6
2024
pubmed:
4
6
2024
entrez:
3
6
2024
Statut:
aheadofprint
Résumé
The use of therapeutic plasma exchange (TPE) for treatment of hypertriglyceridemia-induced acute pancreatitis (HTGP) remains controversial in the literature. This study compared the clinical outcomes of TPE versus conventional therapy in patients with HTGP. Fifty-five patients with HTGP were included. Patients were retrospectively compared in pairs: those who received TPE treatment and those who did not, those whose triglyceride level fell below 500 mg/dL within 48 h, and those who did not, those with and without persistent organ failure. The primary outcome was the percentage of triglyceride reduction within 48 h. Secondary outcomes were the length of hospital stay, mortality, cost-effectiveness, and persistent organ failure. Percentage decrease in triglyceride levels, medical hospitalization costs, and length of hospital stay were higher in the TPE group compared to the non-TPE group (p < 0.05, for each). However, there was no difference regarding persistent organ failure and mortality (p > 0.05, for each). The length of hospital stay, average cost, persistent organ failure, and mortality were similar in both groups whose triglyceride level fell below 500 mg/dL within 48 h and those who did not (p > 0.05, for each). Among patients with persistent organ failure, average cost was higher in the TPE group compared to the non-TPE group (p < 0.05). An independent relation was found between the average cost and persistent organ failure, TPE, length of hospital stay, albumin, and urea values in all patients (p < 0.05, for each). The approach of using TPE for treatment of HTGP was not found to be superior to the conventional treatment. Randomized controlled studies with larger number of patients are needed to gain better understanding of this issue.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
The use of therapeutic plasma exchange (TPE) for treatment of hypertriglyceridemia-induced acute pancreatitis (HTGP) remains controversial in the literature. This study compared the clinical outcomes of TPE versus conventional therapy in patients with HTGP.
METHODS
METHODS
Fifty-five patients with HTGP were included. Patients were retrospectively compared in pairs: those who received TPE treatment and those who did not, those whose triglyceride level fell below 500 mg/dL within 48 h, and those who did not, those with and without persistent organ failure. The primary outcome was the percentage of triglyceride reduction within 48 h. Secondary outcomes were the length of hospital stay, mortality, cost-effectiveness, and persistent organ failure.
RESULTS
RESULTS
Percentage decrease in triglyceride levels, medical hospitalization costs, and length of hospital stay were higher in the TPE group compared to the non-TPE group (p < 0.05, for each). However, there was no difference regarding persistent organ failure and mortality (p > 0.05, for each). The length of hospital stay, average cost, persistent organ failure, and mortality were similar in both groups whose triglyceride level fell below 500 mg/dL within 48 h and those who did not (p > 0.05, for each). Among patients with persistent organ failure, average cost was higher in the TPE group compared to the non-TPE group (p < 0.05). An independent relation was found between the average cost and persistent organ failure, TPE, length of hospital stay, albumin, and urea values in all patients (p < 0.05, for each).
CONCLUSIONS
CONCLUSIONS
The approach of using TPE for treatment of HTGP was not found to be superior to the conventional treatment. Randomized controlled studies with larger number of patients are needed to gain better understanding of this issue.
Identifiants
pubmed: 38831241
doi: 10.1007/s11845-024-03725-2
pii: 10.1007/s11845-024-03725-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Références
Yang AL, McNabb-Baltar J (2020) Hypertriglyceridemia and acute pancreatitis. Pancreatology 20:795–800
doi: 10.1016/j.pan.2020.06.005
pubmed: 32571534
Coskun A, Erkan N, Yakan S et al (2015) Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin. Gastroenterology Review/Przegląd Gastroenterologiczny 10:18–22
pubmed: 25960810
Araz F, Bakiner OS, Bagir GS et al (2022) Continuous insulin therapy versus apheresis in patients with hypertriglyceridemia-associated pancreatitis. Eur J Gastroenterol Hepatol 34:146–152
doi: 10.1097/MEG.0000000000002025
pubmed: 33323759
Click B, Ketchum AM, Turner R et al (2015) The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: a systematic review. Pancreatology 15:313–320
doi: 10.1016/j.pan.2015.02.010
pubmed: 25800175
Ramírez-Bueno A, Salazar-Ramírez C, Cota-Delgado F et al (2014) Plasmapheresis as treatment for hyperlipidemic pancreatitis. Eur J Intern Med 25:160–163
doi: 10.1016/j.ejim.2013.08.701
pubmed: 24012324
Miyamoto K, Horibe M, Sanui M et al (2017) Plasmapheresis therapy has no triglyceride-lowering effect in patients with hypertriglyceridemic pancreatitis. Intensive Care Med 43:949–951
doi: 10.1007/s00134-017-4722-3
pubmed: 28233051
Carrillo IG, Demelo-Rodriguez P, Ferrero MLR et al (2015) Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia. J Clin Lipidol 9:698–702
doi: 10.1016/j.jacl.2015.07.004
Chen Z, Huang X, Zhang M et al (2022) Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis. J Clin Apheresis 37:82–90
doi: 10.1002/jca.21954
pubmed: 34846767
Banks PA, Bollen TL, Dervenis C et al (2013) Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut 62:102–111
doi: 10.1136/gutjnl-2012-302779
pubmed: 23100216
Group PS (2019) Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese Guidelines for the Management of Acute Pancreatitis (Shenyang, 2019) 35:2706–2711
Chatzicostas C, Roussomoustakaki M, Vardas E et al (2002) Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 89:298–302
doi: 10.1046/j.0007-1323.2001.02025.x
Papachristou GI, Muddana V, Yadav D et al (2010) Comparison of BISAP, Ranson’s, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Official Journal of the American College of Gastroenterology | ACG 105:435–441
Yan LH, Hu XH, Chen RX et al (2023) Plasmapheresis compared with conventional treatment for hypertriglyceridemia-induced acute pancreatitis: a systematic review and meta-analysis. J Clin Apheresis 38:4–15
doi: 10.1002/jca.22018
pubmed: 36151902
Hutchison B, Collins J, Makar RS et al (2021) Retrospective analysis of outcomes in patients with acute hypertriglyceridemic pancreatitis treated without therapeutic plasma exchange. Transfusion 61:537–545
doi: 10.1111/trf.16214
pubmed: 33616967
Lu Z, Chen Y, Wu Y et al (2020) The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: a propensity score matching analysis. J Clin Apheresis 35:388–397
doi: 10.1002/jca.21811
pubmed: 32629547
Dichtwald S, Meyer A, Zohar E et al (2022) Hypertriglyceridemia induced pancreatitis: plasmapheresis or conservative management? J Intensive Care Med 37:1174–1178
doi: 10.1177/08850666211054365
pubmed: 34730445
Dehal H, Adashek M (2018) Total plasma exchange in hypertriglyceridemia-induced pancreatitis: case report and literature review. Case Reports Med 2018:4017573
doi: 10.1155/2018/4017573
Gudivada KK, Krishna B (2019) Intensive insulin therapy and plasma exchange in hypertriglyceridaemic acute pancreatitis with multiple organ dysfunction. Natl Med J India 32:352–354
doi: 10.4103/0970-258X.303631
pubmed: 33380630
Eden G, Gradaus F, Brown K et al (2017) Therapeutic plasma exchange for the treatment of hypertriglyceridemia-induced pancreatitis: a case report. Medizinische Klinik-Intensivmedizin und Notfallmedizin 112:471–474
doi: 10.1007/s00063-016-0219-z
pubmed: 27677759
Chen J-H, Yeh J-H, Lai H-W et al (2004) Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol 10:2272
doi: 10.3748/wjg.v10.i15.2272
pubmed: 15259080
pmcid: 4724982
Connelly-Smith L, Alquist CR, Aqui NA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the writing committee of the American Society for apheresis: the ninth special issue. J Clin Apheresis 38:77–278
doi: 10.1002/jca.22043
pubmed: 37017433